SCHEMBL20836131

SCHEMBL20836131

CN(N=Cc1ccccc1C(=O)O)c1nc(-c2ccccc2Cl)cs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631388 1.00 DHODH (1.00) DHODH
SCHEMBL29621431 1.00 DHODH (1.00) DHODH
SCHEMBL19631436 0.92 DHODH (0.85) DHODH
SCHEMBL28664519 0.91 DHODH (0.83) DHODH
SCHEMBL19631450 0.91 DHODH (0.83) DHODH
SCHEMBL28664518 0.91 DHODH (0.83) DHODH
SCHEMBL29859318 0.90 DHODH (1.00) DHODH
SCHEMBL20836122 0.90 DHODH (1.00) DHODH
SCHEMBL19631349 0.90 DHODH (1.00) DHODH
SCHEMBL28975796 0.90 DHODH (0.81) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117769544-A Polysubstituted thiazole derivative and application thereof in disease treatment 上海汇伦医药股份有限公司 2024-03-26 — — CN disclosed
CN-113773275-B Antiviral compound and preparation method thereof 广东中科药物研究有限公司 2023-04-25 — — CN disclosed
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-28 — — US disclosed
CN-115701427-A Polysubstituted thiazole derivatives and their use in the treatment of diseases 上海汇伦医药股份有限公司 2023-02-10 — — CN disclosed
WO-2023011312-A1 MULTI-SUBSTITUTED THIAZOLE DERIVATIVE AND APPLICATION THEREOF IN DISEASE TREATMENT 上海汇伦医药股份有限公司 2023-02-09 — — WO disclosed
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 — — US disclosed
CN-107375279-B Use of novel thiazole derivatives for the treatment of inflammatory bowel disease 华东理工大学 2022-11-01 — — CN disclosed
CN-107382902-B Thiazole derivative and application thereof 华东理工大学 2022-08-12 — — CN disclosed
CN-107459496-B Use of thiazole derivatives for treating viral infections 华东理工大学 2022-07-19 — — CN disclosed
CN-113416172-B Antiviral compound and preparation method thereof 广东中科药物研究有限公司 2022-06-21 — — CN disclosed
EP-3459937-B1 THIAZOLE DERIVATIVE AND APPLICATIONS UNIV EAST CHINA SCIENCE & TECH (CN) 2021-12-29 — — EP disclosed
CN-113773275-A Antiviral compound and preparation method thereof 广东中科药物研究有限公司 2021-12-10 — — CN disclosed
CN-113416172-A Antiviral compound and preparation method thereof 广东中科药物研究有限公司 2021-09-21 — — CN disclosed
CN-112707874-A Antiviral compound and preparation method thereof 广东中科药物研究有限公司 2021-04-27 — — CN disclosed
US-10919869-B2 Thiazole derivative and applications EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-02-16 — — US disclosed
CN-106892878-B Thiazole derivative and application thereof in inhibiting dihydroorotate dehydrogenase 华东理工大学 2020-01-10 — — CN disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 — — US disclosed
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-05-09 — — US disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases FABP2, SLC10A2, ALPI DHODH 803/4885
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS DHODH, DLD, THOC2 DHODH 1/4885
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES FABP2, SLC10A2, ALPI DHODH 803/4885
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885
US-10919869-B2 Thiazole derivative and applications DHODH, DLD, THOC2 DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback